1-2 of 2
Kilian Guse
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer

Ilkka Liikanen, Siri Tähtinen, Kilian Guse, Theresia Gutmann, Paula Savola, Minna Oksanen, Anna Kanerva, Akseli Hemminki
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (9): 2259–2269.
https://doi.org/10.1158/1535-7163.MCT-15-0819
Published: 01 September 2016
View article titled, Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer
Open the PDF for Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer in another window
Includes: Supplementary data
Journal Articles

Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses

Kilian Guse, Tuuli Ranki, Martti Ala-Opas, Petri Bono, Merja Särkioja, Maria Rajecki, Anna Kanerva, Tanja Hakkarainen, Akseli Hemminki
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (10): 2728–2736.
https://doi.org/10.1158/1535-7163.MCT-07-0176
Published: 15 October 2007
View article titled, Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses
Open the PDF for Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses in another window